Viceton Tablets for Dogs, 250mg

Supplied By: Bimeda (1VIC007)


SKU
005795


Unit of
Measure
500 Count


Pack
Type
Bottle


Case
Qty
12

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Nov- 2024 Oct- 2024 Sep- 2024 Aug- 2024 Jul- 2024 Jun- 2024 May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023
{{purchaseHistoryItem}}


SKU
005795


Size
500 Count

Case
Qty
12

Purchase History

Nov- 2024 {{productPurchaseHistory['005795'][0]}} Apr- 2024 {{productPurchaseHistory['005795'][0+7]}}
Oct- 2024 {{productPurchaseHistory['005795'][1]}} Mar- 2024 {{productPurchaseHistory['005795'][1+7]}}
Sep- 2024 {{productPurchaseHistory['005795'][2]}} Feb- 2024 {{productPurchaseHistory['005795'][2+7]}}
Aug- 2024 {{productPurchaseHistory['005795'][3]}} Jan- 2024 {{productPurchaseHistory['005795'][3+7]}}
Jul- 2024 {{productPurchaseHistory['005795'][4]}} Dec- 2023 {{productPurchaseHistory['005795'][4+7]}}
Jun- 2024 {{productPurchaseHistory['005795'][5]}} Nov- 2023 {{productPurchaseHistory['005795'][5+7]}}
May- 2024 {{productPurchaseHistory['005795'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

VicetonĀ® is a broad-spectrum antibiotic indicated for the following conditions in dogs: Bacterial pulmonary infections caused by Staphylococcus aureus, Streptococcus pyogenes and Brucella bronchiseptica, Infections of the urinary tract caused by Escherichia coli, Proteus vulgaris, Corynebacterium renale, Streptococcus spp. and hemolytic Staphylococcus, Enteritis caused by E. coli, Proteus spp., Salmonella spp., and Pseudomonas spp., Infections associated with canine distemper caused by B. bronchiseptica, E. coli, P. aeruginosa, Proteus spp., Shigella spp. and Neisseria catarrhalis

Features & Benefits

  • Diffuses readily into all body tissues and fluids
  • Easy to administer
  • Tablets are small, scored, and coated for easy pilling
  • Provides rapid clinical response against a wide range of pathogens
  • Most susceptible infectious disease organisms will respond to chloramphenicol therapy in three to five days
  • Reaches significant concentrations in the aqueous and vitreous humors of the eye and has marked ability to diffuse into the cerebrospinal fluid
  • Low resistance
  • Approved by FDA